These are mechanically computed values based on a residual income model. They are not a forecast of market prices or a recommendation of any investment action, and do not predict or guarantee future share prices. Historical values are computed retrospectively using current guidance-achievement statistics.
| Metric | Current Period | Same Period of Previous Year | YoY |
|---|---|---|---|
| Revenue | ¥15.90B | ¥14.62B | +8.8% |
| Operating Income | ¥2.96B | ¥3.27B | -9.4% |
| Equity-Method Investment Gain/Loss | - | - | - |
| Ordinary Income | ¥3.28B | ¥3.22B | +1.8% |
| Net Income | ¥2.31B | ¥2.30B | +0.3% |
| ROE | 3.6% | 3.5% | - |
During the quarter, the Company secured revenue growth, but profitability in its core business deteriorated, while an increase in non-operating income supported Ordinary Income and Net Income. Revenue was ¥15.90B (+8.8% year on year), while Operating Income was ¥2.96B (▲9.4% YoY), with a decline in the gross profit margin and an increase in SG&A expenses being the primary causes of the decline in Operating Income. Ordinary Income was ¥3.28B (+1.8% YoY), and Net Income (net income attributable to owners of the parent) was ¥2.31B (+0.3% YoY), supported by an increase in non-operating income, including a reversal of allowance for doubtful accounts and foreign exchange gains.
【Revenue】Revenue was ¥15.90B, representing an 8.8% increase year on year. The Company operates a single business involving the manufacture and sale of medical equipment, and no reporting segments are identified; therefore, regional and business-line breakdowns have not been disclosed. Steady demand, primarily from the domestic market, appears to have contributed to the revenue increase.
【Profit and Loss】Operating Income was ¥2.96B, representing a 9.4% decline year on year. The cost-of-sales ratio increased to 42.3% (40.0% in the previous year), while the gross profit margin declined by 2.3pt to 57.7% (60.0% in the previous year). SG&A expenses increased to ¥6.21B (+12.9%), outpacing revenue growth (+8.8%), and the SG&A ratio rose by 1.4pt to 39.0% (37.6% in the previous year). As a result, the Operating Income margin declined by 3.8pt to 18.6% (22.4% in the previous year). Ordinary Income was ¥3.28B (+1.8% YoY), supported by a sharp increase in non-operating income to ¥0.334B (¥0.028B in the previous year). The main components were a ¥0.203B reversal of allowance for doubtful accounts and ¥0.028B in foreign exchange gains. Extraordinary Losses were limited to ¥0.025B (loss on disposal of fixed assets) as a temporary factor, and Net Income was ¥2.31B (+0.3% YoY). Overall, the results were characterized by higher revenue and lower Operating Income, while increases in non-operating income enabled the Company to secure growth in Ordinary Income and Net Income.
【Profitability】The Operating Income margin was 18.6%, down 3.8pt from 22.4% in the same period of the previous year, while the Net Income margin was 14.5%, down 1.2pt from 15.8% in the previous year. The gross profit margin of 57.7% (60.0% in the previous year) and SG&A ratio of 39.0% (37.6% in the previous year) explain the deterioration in margins, with higher costs being the primary cause of the decline in profitability.【Cash Quality】Cash and deposits were ¥9.62B, down 23.0% from ¥12.49B at the end of the previous fiscal year, while accounts receivable increased to ¥15.97B (+9.8%), and inventories remained broadly flat at ¥20.13B. Accounts receivable increased faster than revenue, suggesting a buildup in the collection of funds.【Investment Efficiency】ROE was 3.6%, broadly unchanged from 3.5% in the same period of the previous year. Capital efficiency remains limited relative to the high equity level represented by an Equity Ratio of 84.1%.【Financial Soundness】The Equity Ratio was 84.1%, improving by 2.0pt from 82.1% in the previous year. The current ratio was extremely high at 417.2% (current assets of ¥47.44B / current liabilities of ¥11.37B). Interest-bearing debt consisted solely of ¥2.896B in short-term borrowings, while cash and deposits of ¥9.62B substantially exceeded this amount, indicating a conservative financial structure that is effectively close to debt-free.
As the Company has not disclosed a cash flow statement, cash trends are analyzed based on changes in the balance sheet. Cash and deposits were ¥9.62B, down ¥2.87B (▲23.0%) from ¥12.49B at the end of the previous fiscal year. Multiple factors contributed to cash outflows and the buildup of funds, including a ¥1.42B increase in accounts receivable, a ¥0.61B increase in property, plant and equipment (capital expenditures centered on buildings and structures), a ¥1.35B decline in income taxes payable (settlement of taxes for the previous fiscal year), and a ¥0.98B decline in the provision for bonuses (due to payments). Inventories remained at a high level of ¥20.13B, making the reduction of working capital (accounts receivable and inventories) an important factor in restoring cash on hand going forward.
Operating Income of ¥2.96B represents recurring earnings from the core business, while the ¥0.32B difference from Ordinary Income reflects the net amount of non-operating income of ¥0.334B (including a ¥0.203B reversal of allowance for doubtful accounts and ¥0.028B in foreign exchange gains) and non-operating expenses of ¥0.018B (including ¥0.006B in interest expenses). Since items with a high degree of non-recurring nature account for most of this difference, its reproducibility is considered limited. Extraordinary income was ¥0.001B and Extraordinary Losses were ¥0.025B (loss on disposal of fixed assets), both immaterial, and their impact on Net Income was limited. The effective tax rate was 29.1%, slightly higher than 28.0% in the previous year. Comprehensive Income was ¥2.33B, broadly in line with Net Income of ¥2.31B. The main factors behind the difference were a +¥0.02B valuation difference on available-for-sale securities, a +¥0.01B foreign currency translation adjustment, and a ▲¥0.02B adjustment related to retirement benefits; the divergence from Net Income was small.
Progress against the full-year plan was 25.2% for Revenue, 27.7% for Operating Income, 30.4% for Ordinary Income, and 28.9% for Net Income. Accordingly, each profit item from Operating Income downward is progressing faster than the 25% benchmark for simple progress. However, this outperformance was largely supported by non-operating factors specific to Q1, such as the reversal of allowance for doubtful accounts and foreign exchange gains, and attention is required regarding sustainability throughout the full year. While the Company’s full-year plan calls for Revenue growth of +6.8%, it forecasts declines of ▲15.1% in Operating Income and ▲14.2% in Ordinary Income. The pace of profitability recovery from the second half onward will therefore be key to achieving the plan. No revisions were made to the earnings forecast during the quarter, while the dividend forecast was revised.
For the fiscal year ending March 2027, the dividend forecast consists of an interim regular dividend of ¥0 and commemorative dividend of ¥25, and a year-end regular dividend of ¥56 and commemorative dividend of ¥0, for a planned annual total of ¥81. The Payout Ratio against full-year forecast EPS of ¥114.02 is approximately 71.0% (¥81/¥114.02), a relatively high level. Although this is underpinned by a strong financial base reflected in an Equity Ratio of 84.1%, the high Payout Ratio means that continued generation of stable Operating Cash Flow is a prerequisite for sustainable shareholder returns. No information on share repurchases is available, and shareholder returns consist solely of dividends.
Gross Profit Margin Decline and Cost Increase Risk: The gross profit margin was 57.7%, down 2.3pt from 60.0% in the previous year, while SG&A expenses increased to ¥6.21B (+12.9%), outpacing revenue growth of +8.8%. As a result, the Operating Income margin declined by 3.8pt to 18.6%, making improvement of the cost structure a key issue.
Working Capital Buildup Risk: Accounts receivable were ¥15.97B (+9.8%), and inventories were ¥20.13B; both remained at high levels comparable to quarterly revenue of ¥15.90B. The increase in accounts receivable at a pace exceeding revenue growth suggests a buildup in fund collection.
Dependence on Non-Recurring Income Risk: Growth in Ordinary Income and Net Income was supported by non-operating income items with a high degree of non-recurring nature, including a ¥0.203B reversal of allowance for doubtful accounts and ¥0.028B in foreign exchange gains. The reproducibility of these items is limited.
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Income margin | 18.6% | 4.3% (1.7%–6.9%) | +14.4pt |
| Net Income margin | 14.5% | 3.8% (1.5%–5.1%) | +10.7pt |
Both the Operating Income margin and Net Income margin significantly exceeded the industry median, placing the Company among the industry leaders in profitability.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue growth rate (YoY) | 8.8% | 3.1% (-0.6%–11.7%) | +5.7pt |
The Revenue growth rate exceeded the industry median but did not reach the upper end of the industry IQR (11.7%), placing growth within the upper range of the industry.
※Source: Compiled by the Company
The Operating Income margin was 18.6%, down 3.8pt from 22.4% in the previous year, due to a decline in the gross profit margin (-2.3pt) and an increase in SG&A expenses (+12.9%, exceeding revenue growth of +8.8%). Attention should be paid to whether the deterioration in core-business profitability will continue.
Growth in Ordinary Income and Net Income was secured through non-operating income such as the reversal of allowance for doubtful accounts and foreign exchange gains, in contrast to the declining trend in Operating Income. The reproducibility of this non-operating income will be tested in future quarters.
Full-year progress was ahead of the standard 25% benchmark at 30.4% for Ordinary Income and 28.9% for Net Income. However, the full-year plan itself anticipates declines in Operating Income and Ordinary Income, making the impact of the reversal of non-recurring support in the first half on second-half performance a key focus.
This is a reference range mechanically calculated solely from publicly disclosed data using a residual income model (Ohlson-type model with an explicit 5-year fade period). It is not a forecast of the market share price or a recommendation of any specific investment action.
| Scenario | Theoretical Share Price |
|---|---|
| bear | ¥994 |
| base | ¥1,006 |
| bull | ¥1,029 |
| Calculation Assumption | Value |
|---|---|
| Book value per share (BPS) | ¥919 |
| Adjusted forecast EPS | ¥118.2 |
| Cost of equity capital r | 9.65% (10-year Japanese government bond 2.65% + equity risk premium 6.00% + size premium 1.00%) |
| Residual income persistence coefficient ω / explicit forecast period | 0.62 / 5 years |
| Assumed Payout Ratio | 21.9% |
| Forecast EPS confidence adjustment | ×1.037 (based on the industry’s historical guidance achievement rate) |
| Implied PBR / PER |
Sensitivity: ¥978–¥1,036 at ±1% for the cost of equity capital, and ¥1,004–¥1,010 at ±0.1 for ω.
Notes:
(Calculation model: residual income model / interest rate reference month: 2026-06 / this value does not predict or guarantee the future share price)
This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting a professional as necessary.
---End of Report---
| 1.10x / 8.5x |